"treatment survival" trang 11 - tải miễn phí từ tailieunhanh
The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients

The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
8    82    1
Resolution of severe hyponatraemia is associated with improved survival in patients with cancer

Resolution of severe hyponatraemia is associated with improved survival in patients with cancer
5    28    1
Up-regulation of DGAT1 in cancer tissues and tumor-infiltrating macrophages influenced survival of patients with gastric cancer

Up-regulation of DGAT1 in cancer tissues and tumor-infiltrating macrophages influenced survival of patients with gastric cancer
10    55    1
Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer

Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer
7    43    1
A 10-year retrospective study of lung cancer in Uganda

A 10-year retrospective study of lung cancer in Uganda
8    24    1
A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer

A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer
19    1    1
A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation

A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation
15    1    1
Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: A real world study

Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: A real world study
8    1    1
Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: A retrospective study in China

Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: A retrospective study in China
11    72    0
Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2- negative metastatic breast cancer: A network meta-analysis

Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2- negative metastatic breast cancer: A network meta-analysis
17    79    0
Trastuzumab use in older patients with HER2-positive metastatic breast cancer: Outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015)

Trastuzumab use in older patients with HER2-positive metastatic breast cancer: Outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015)
10    60    0
Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: A prospective, phase II, multicentre, single-arm study

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: A prospective, phase II, multicentre, single-arm study
7    80    0
Optimal treatment for elderly patients with resectable proximal gastric carcinoma: A real world study based on National Cancer Database

Optimal treatment for elderly patients with resectable proximal gastric carcinoma: A real world study based on National Cancer Database
10    69    0
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective

Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective
10    54    1
Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: A comparative study

Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: A comparative study
8    62    1
Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: A retrospective study

Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: A retrospective study
8    43    1
Predictive value of dynamic change of haemoglobin levels during therapy on treatment outcomes in patients with Enneking stage IIB extremity osteosarcoma

Predictive value of dynamic change of haemoglobin levels during therapy on treatment outcomes in patients with Enneking stage IIB extremity osteosarcoma
8    55    1
Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin

Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
10    28    1
Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: Does sequence matter?

Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: Does sequence matter?
8    68    1
Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: Result of an institution database from South Korea

Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: Result of an institution database from South Korea
8    46    1